{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:24:04Z","timestamp":1793316244179,"version":"4.5.0"},"reference-count":357,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.pharmthera.2020.107554","type":"journal-article","created":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T02:29:25Z","timestamp":1587263365000},"page":"107554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"special_numbering":"C","title":["Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders"],"prefix":"10.1016","volume":"213","author":[{"given":"Eva","family":"Gil-Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Jos\u00e9","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Remi\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2020.107554_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10571-004-1374-y","article-title":"Dynamics of CNS barriers: Evolution, differentiation, and modulation","volume":"25","author":"Abbott","year":"2005","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0020","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.2042-7158.2011.01309.x","article-title":"Up-regulation of P-glycoprotein reduces intracellular accumulation of beta amyloid: Investigation of P-glycoprotein as a novel therapeutic target for Alzheimer's disease","volume":"63","author":"Abuznait","year":"2011","journal-title":"The Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0025","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.2174\/138161211797440186","article-title":"Breast cancer resistance protein and P-glycoprotein in brain cancer: Two gatekeepers team up","volume":"17","author":"Agarwal","year":"2011","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jns.2016.07.041","article-title":"Association between MDR1 gene polymorphisms and Parkinson's disease in Asian and Caucasian populations: A meta-analysis","volume":"368","author":"Ahmed","year":"2016","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2009.11.051","article-title":"Exposure to antiepileptic drugs does not alter the functionality of P-glycoprotein in brain capillary endothelial and kidney cell lines","volume":"628","author":"Ambroziak","year":"2010","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0045","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/00005072-199911000-00005","article-title":"Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals","volume":"58","author":"An","year":"1999","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0050","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.addr.2011.11.008","article-title":"Cerebral expression of drug transporters in epilepsy","volume":"64","author":"Aronica","year":"2012","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/bs.apha.2014.06.010","article-title":"Functional expression of drug transporters in glial cells: Potential role on drug delivery to the CNS","volume":"71","author":"Ashraf","year":"2014","journal-title":"Advances in Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/brain\/awr298","article-title":"Blood-brain barrier P-glycoprotein function in Alzheimer's disease","volume":"135","author":"van Assema","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0065","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s11307-012-0556-0","article-title":"P-glycoprotein function at the blood-brain barrier: Effects of age and gender","volume":"14","author":"van Assema","year":"2012","journal-title":"Molecular Imaging and Biology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0039-1678581","article-title":"Current and future treatments in Alzheimer's disease","volume":"39","author":"Atri","year":"2019","journal-title":"Seminars in Neurology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0075","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00424-006-0160-8","article-title":"Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1\/ABCC1)","volume":"453","author":"Bakos","year":"2007","journal-title":"Pfl\u00fcgers Archiv-European Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.toxlet.2014.01.039","article-title":"Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases--a mechanistic approach","volume":"230","author":"Baltazar","year":"2014","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0085","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.drudis.2014.11.011","article-title":"Targeting xenobiotic receptors PXR and CAR in human diseases","volume":"20","author":"Banerjee","year":"2015","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0090","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/0271678X17705786","article-title":"Lysophosphatidic acid and amitriptyline signal through LPA1R to reduce P-glycoprotein transport at the blood-brain barrier","volume":"38","author":"Banks","year":"2018","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0095","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.neuropharm.2008.02.008","article-title":"Glutamate is critically involved in seizure-induced overexpression of P-glycoprotein in the brain","volume":"54","author":"Bankstahl","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0100","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.ejca.2004.05.010","article-title":"The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours","volume":"40","author":"Bart","year":"2004","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0105","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.neurobiolaging.2008.02.002","article-title":"Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration","volume":"30","author":"Bartels","year":"2009","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0110","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-008-0030-y","article-title":"Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA","volume":"115","author":"Bartels","year":"2008","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0115","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1124\/mol.106.029512","article-title":"Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier","volume":"71","author":"Bauer","year":"2007","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0120","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/mol.107.041210","article-title":"Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling","volume":"73","author":"Bauer","year":"2008","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0125","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1124\/mol.106.023796","article-title":"In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation","volume":"70","author":"Bauer","year":"2006","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0130","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/bj3260539","article-title":"P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain","volume":"326","author":"Beaulieu","year":"1997","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0135","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/BF00293387","article-title":"The multidrug-resistance gene MDR1 is expressed in human glial tumors","volume":"82","author":"Becker","year":"1991","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0140","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2174\/1381612043384844","article-title":"ABC transporters and the blood-brain barrier","volume":"10","author":"Begley","year":"2004","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2004.08.001","article-title":"Delivery of therapeutic agents to the central nervous system: The problems and the possibilities","volume":"104","author":"Begley","year":"2004","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0150","series-title":"Peptide transport and delivery into the central nervous system","first-page":"39","article-title":"Structural and functional aspects of the blood-brain barrier","author":"Begley","year":"2003"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0155","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1517\/17425255.3.6.819","article-title":"Drug transport across the placenta, role of the ABC drug efflux transporters","volume":"3","author":"Behravan","year":"2007","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0160","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/bcpt.12960","article-title":"Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 polymorphisms on pharmacokinetics and safety of Aripiprazole in healthy volunteers","volume":"122","author":"Belmonte","year":"2018","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.schres.2016.02.036","article-title":"Morphometric analysis of the cerebral expression of ATP-binding cassette transporter protein ABCB1 in chronic schizophrenia: Circumscribed deficits in the habenula","volume":"177","author":"Bernstein","year":"2016","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0170","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.stem.2009.01.007","article-title":"PTEN\/PI3K\/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells","volume":"4","author":"Bleau","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0175","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00137696-200301010-00002","article-title":"Brain-targeted drug delivery","volume":"1","author":"Bodor","year":"2003","journal-title":"American Journal of Drug Delivery"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0180","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/bj20020957","article-title":"Structure and function of efflux pumps that confer resistance to drugs","volume":"376","author":"Borges-Walmsley","year":"2003","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0185","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00424-006-0054-9","article-title":"Multidrug resistance-associated proteins 3, 4, and 5","volume":"453","author":"Borst","year":"2007","journal-title":"Pfl\u00fcgers Archiv-European Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0195","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.expneurol.2008.06.010","article-title":"Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: Therapeutic implications for amyotrophic lateral sclerosis","volume":"213","author":"Boston-Howes","year":"2008","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0200","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.nbd.2006.06.014","article-title":"The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy","volume":"24","author":"Brandt","year":"2006","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0205","doi-asserted-by":"crossref","first-page":"690121","DOI":"10.4061\/2011\/690121","article-title":"Beta-amyloid downregulates MDR1-P-glycoprotein (Abcb1) expression at the blood-brain barrier in mice","volume":"2011","author":"Brenn","year":"2011","journal-title":"International Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0210","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0215","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","article-title":"Diagnosis of multiple sclerosis: Progress and challenges","volume":"389","author":"Brownlee","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0220","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/1567205013666161201201227","article-title":"Lack of P-glycoprotein results in impairment of removal of beta-amyloid and increased intraparenchymal cerebral amyloid Angiopathy after active immunization in a transgenic mouse model of Alzheimer's disease","volume":"14","author":"Bruckmann","year":"2017","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0225","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00420-019-01414-7","article-title":"Common mental disorders through the eyes of German employees: Attributed relevance of work-related causes and prevention measures assessed by a standardised survey","volume":"92","author":"Burgess","year":"2019","journal-title":"International Archives of Occupational and Environmental Health"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0230","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.arcmed.2014.11.018","article-title":"Role of the blood-brain barrier in the nutrition of the central nervous system","volume":"45","author":"Campos-Bedolla","year":"2014","journal-title":"Archives of Medical Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0235","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3233\/JAD-2010-100462","article-title":"Apical-to-basolateral transport of amyloid-\u03b2 peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein","volume":"22","author":"Candela","year":"2010","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0240","doi-asserted-by":"crossref","first-page":"15930","DOI":"10.1073\/pnas.1203534109","article-title":"Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain","volume":"109","author":"Cannon","year":"2012","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0245","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/jcbfm.2012.174","article-title":"Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers","volume":"33","author":"Cartwright","year":"2013","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0250","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/jphp.12033","article-title":"Alteration in P-glycoprotein at the blood-brain barrier in the early period of MCAO in rats","volume":"65","author":"Cen","year":"2013","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0255","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neulet.2016.12.049","article-title":"Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model","volume":"639","author":"Chan","year":"2017","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0260","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJMra022308","article-title":"Epilepsy","volume":"349","author":"Chang","year":"2003","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0265","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.2174\/1570159X15666170504095823","article-title":"Opioids and the blood-brain barrier: A dynamic interaction with consequences on drug disposition in brain","volume":"15","author":"Chaves","year":"2017","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0270","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","article-title":"P-glycoprotein deficiency at the blood-brain barrier increases amyloid-\u03b2 deposition in an Alzheimer disease mouse model","volume":"115","author":"Cirrito","year":"2005","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0275","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2896","article-title":"Alzheimer's disease: Strategies for disease modification","volume":"9","author":"Citron","year":"2010","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0280","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1359-6446(03)02827-7","article-title":"In silico prediction of blood-brain barrier permeation","volume":"8","author":"Clark","year":"2003","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0285","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1360704","article-title":"Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line","volume":"258","author":"Cole","year":"1992","journal-title":"Science-New York Then Washington"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0290","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0295","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1124\/pr.58.2.7","article-title":"The ATP-binding cassette transporters and their implication in drug disposition: A special look at the heart","volume":"58","author":"Couture","year":"2006","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0300","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13195-019-0529-5","article-title":"The \"rights\" of precision drug development for Alzheimer's disease","volume":"11","author":"Cummings","year":"2019","journal-title":"Alzheimer's Research & Therapy"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0305","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/pr.58.2.3","article-title":"Multidrug resistance-associated proteins: Expression and function in the central nervous system","volume":"58","author":"Dallas","year":"2006","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0310","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1211\/0022357021778880","article-title":"Distribution of domperidone into the rat brain is increased by brain ischaemia or treatment with the P-glycoprotein inhibitor verapamil","volume":"54","author":"Dan","year":"2002","journal-title":"The Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0320","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-0028-1103272","article-title":"ABC transporter (P-gp\/ABCB1, MRP1\/ABCC1, BCRP\/ABCG2) expression in the developing human CNS","volume":"39","author":"Daood","year":"2008","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0325","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.neuroscience.2006.07.056","article-title":"Differential regulation of transport proteins in the periinfarct region following reversible middle cerebral artery occlusion in rats","volume":"142","author":"Dazert","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0330","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-2275(20)31588-1","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"42","author":"Dean","year":"2001","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0335","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-\u03b2 peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0340","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ijc.10135","article-title":"Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines","volume":"98","author":"Decl\u00e8ves","year":"2002","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0345","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1158\/1078-0432.CCR-06-2854","article-title":"The blood-brain barrier and cancer: Transporters, treatment, and Trojan horses","volume":"13","author":"Deeken","year":"2007","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0350","doi-asserted-by":"crossref","first-page":"15035","DOI":"10.1038\/nrdp.2015.35","article-title":"HIV infection","volume":"1","author":"Deeks","year":"2015","journal-title":"Nature Reviews. Disease Primers"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0355","doi-asserted-by":"crossref","DOI":"10.1177\/1179069517701741","article-title":"Spatiotemporal changes in P-glycoprotein levels in brain and peripheral tissues following ischemic stroke in rats","volume":"11","author":"DeMars","year":"2017","journal-title":"J Exp Neurosci"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0360","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1537-1891(02)00201-X","article-title":"Drug transport to the brain: Key roles for the efflux pump P-glycoprotein in the blood-brain barrier","volume":"38","author":"Demeule","year":"2002","journal-title":"Vascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0365","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ijc.1306","article-title":"Expression of multidrug-resistance P-glycoprotein (MDR1) in human brain tumors","volume":"93","author":"Demeule","year":"2001","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0370","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1248\/bpb.b18-00937","article-title":"MicroRNA-146a-5p downregulates the expression of P-glycoprotein in rats with Lithium-Pilocarpine-induced status Epilepticus","volume":"42","author":"Deng","year":"2019","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0380","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejmech.2019.03.009","article-title":"Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review","volume":"169","author":"Dinda","year":"2019","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0385","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JAD-2012-112189","article-title":"ABCG2-and ABCG4-mediated efflux of amyloid-\u03b2 peptide 1-40 at the mouse blood-brain barrier","volume":"30","author":"Do","year":"2012","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0390","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1046\/j.1528-1157.2001.12301.x","article-title":"Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy","volume":"42","author":"Dombrowski","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0395","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.7150\/thno.21254","article-title":"Current strategies for brain drug delivery","volume":"8","author":"Dong","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0400","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(08)60694-7","article-title":"Stroke","volume":"371","author":"Donnan","year":"2008","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0405","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/03602532.2014.882353","article-title":"Phase 0 and phase III transport in various organs: Combined concept of phases in xenobiotic transport and metabolism","volume":"46","author":"Doring","year":"2014","journal-title":"Drug Metabolism Reviews"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0410","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.med.60.041807.123549","article-title":"Emerging concepts in the immunopathogenesis of AIDS","volume":"60","author":"Douek","year":"2009","journal-title":"Annual Review of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0415","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.1038\/sj.onc.1206938","article-title":"Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)","volume":"22","author":"Doyle","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0420","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"Doyle","year":"1998","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0425","doi-asserted-by":"crossref","first-page":"ra72","DOI":"10.1126\/scisignal.2001213","article-title":"Apolipoprotein E controls ATP-binding cassette transporters in the ischemic brain","volume":"3","author":"ElAli","year":"2010","journal-title":"Sci Signal"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0430","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/jphp.12329","article-title":"The effects of human immunodeficiency virus infection on the expression of the drug efflux proteins P-glycoprotein and breast cancer resistance protein in a human intestine model","volume":"67","author":"Ellis","year":"2015","journal-title":"The Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0435","article-title":"New anticonvulsant candidates prevent P-glycoprotein (P-gp) overexpression in a pharmacoresistant seizure model in mice","volume":"106451","author":"Enrique","year":"2019","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060848","article-title":"A new strategy for glioblastoma treatment: In vitro and in vivo preclinical characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine dual Src\/P-glycoprotein inhibitor","volume":"11","author":"Fallacara","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0450","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2013.06.044","article-title":"Association between the ABCG2 C421A polymorphism and Alzheimer's disease","volume":"550","author":"Feh\u00e9r","year":"2013","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0455","first-page":"1","article-title":"The potential role of human multidrug resistance protein 1 (MDR1) and multidrug resistance-associated protein 2 (MRP2) in the transport of Huperzine A in vitro","author":"Fei","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0460","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S1474-4422(13)70109-1","article-title":"P-glycoprotein expression and function in patients with temporal lobe epilepsy: A case-control study","volume":"12","author":"Feldmann","year":"2013","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0465","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.0022-3042.2001.00660.x","article-title":"P-glycoprotein expression in rat brain endothelial cells: Evidence for regulation by transient oxidative stress","volume":"80","author":"Felix","year":"2002","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0470","doi-asserted-by":"crossref","first-page":"39557","DOI":"10.1021\/acsami.8b17224","article-title":"PEGylated PLGA nanoparticles as a smart carrier to increase the cellular uptake of a coumarin-based monoamine oxidase B inhibitor","volume":"10","author":"Fernandes","year":"2018","journal-title":"ACS Applied Materials & Interfaces"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0475","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0480","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.foodres.2017.10.010","article-title":"Flavonoid compounds as reversing agents of the P-glycoprotein-mediated multidrug resistance: An in vitro evaluation with focus on antiepileptic drugs","volume":"103","author":"Ferreira","year":"2018","journal-title":"Food Research International"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0485","first-page":"1","article-title":"Silymarin as a flavonoid-type P-glycoprotein inhibitor with impact on the pharmacokinetics of carbamazepine, oxcarbazepine and phenytoin in rats","author":"Ferreira","year":"2019","journal-title":"Drug and Chemical Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0490","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","article-title":"Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis","volume":"81","author":"Frakes","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0495","first-page":"5114","article-title":"The effect of P-glycoprotein on paclitaxel brain and brain tumor distribution in mice","volume":"63","author":"Gallo","year":"2003","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules22040600","article-title":"Cellular models and in vitro assays for the screening of modulators of P-gp, MRP1 and BCRP","volume":"22","author":"Gameiro","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0505","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1089\/dna.2018.4391","article-title":"ABCB1 1199G>a polymorphism affects the intracellular accumulation of antidepressants in LLC-PK1 recombinant cell lines","volume":"37","author":"Gao","year":"2018","journal-title":"DNA and Cell Biology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0510","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2007.04.044","article-title":"Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS","volume":"1157","author":"Garbuzova-Davis","year":"2007","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0515","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainres.2012.05.056","article-title":"Impaired blood-brain\/spinal cord barrier in ALS patients","volume":"1469","author":"Garbuzova-Davis","year":"2012","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0520","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fncel.2014.00021","article-title":"Blood-CNS barrier impairment in ALS patients versus an animal model","volume":"8","author":"Garbuzova-Davis","year":"2014","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0525","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/jpet.102.035014","article-title":"Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition","volume":"302","author":"Gerk","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0530","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024125","article-title":"Genetics of amyotrophic lateral sclerosis","volume":"8","author":"Ghasemi","year":"2018","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0535","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1750-3639.2010.00389.x","article-title":"P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) localize in the microvessels forming the blood-tumor barrier in ependymomas","volume":"20","author":"Ginguen\u00e9","year":"2010","journal-title":"Brain Pathology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0540","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.neuroscience.2007.02.055","article-title":"Neuroprotective role of the innate immune system by microglia","volume":"147","author":"Glezer","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0545","first-page":"175","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"Pharmacy and Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0550","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10637-017-0539-8","article-title":"ATP-binding cassette transporters limit the brain penetration of Wee1 inhibitors","volume":"36","author":"de Gooijer","year":"2018","journal-title":"Investigational New Drugs"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0555","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1021\/acs.molpharmaceut.8b00742","article-title":"ABCB1 attenuates the brain penetration of the PARP inhibitor AZD2461","volume":"15","author":"de Gooijer","year":"2018","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0560","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.neo.2018.05.001","article-title":"Improved brain penetration and antitumor efficacy of Temozolomide by inhibition of ABCB1 and ABCG2","volume":"20","author":"de Gooijer","year":"2018","journal-title":"Neoplasia"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0565","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.bjp.0705227","article-title":"Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin","volume":"139","author":"Goralski","year":"2003","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0570","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1023\/A:1012866803188","article-title":"Overview: ABC transporters and human disease","volume":"33","author":"Gottesman","year":"2001","journal-title":"Journal of Bioenergetics and Biomembranes"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0575","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22101484","article-title":"In vitro assessment of the effect of antiepileptic drugs on expression and function of ABC transporters and their interactions with ABCC2","volume":"22","author":"Grewal","year":"2017","journal-title":"Molecules"},{"issue":"871\u2013895","key":"10.1016\/j.pharmthera.2020.107554_bb0580","first-page":"vii","article-title":"Epidemiology of ischemic and hemorrhagic stroke: Incidence, prevalence, mortality, and risk factors","volume":"26","author":"Grysiewicz","year":"2008","journal-title":"Neurologic Clinics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0585","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0092-8674(93)90312-E","article-title":"Cellular processing of \u03b2-amyloid precursor protein and the genesis of amyloid \u03b2-peptide","volume":"75","author":"Haass","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0590","first-page":"211","article-title":"Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma","volume":"92","author":"Haga","year":"2001","journal-title":"Cancer Science"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0595","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/1073110518804230","article-title":"Alzheimer disease: Perspectives from epidemiology and genetics","volume":"46","author":"Haines","year":"2018","journal-title":"The Journal of Law, Medicine & Ethics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0600","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nature Reviews. Disease Primers"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0605","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0610","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0615","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/mi.10.5.6","article-title":"Regulation of ABC transporters at the blood-brain barrier: New targets for CNS therapy","volume":"10","author":"Hartz","year":"2010","journal-title":"Molecular Interventions"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0620","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1096\/fj.08-106997","article-title":"Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier","volume":"22","author":"Hartz","year":"2008","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0625","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/mol.104.001503","article-title":"Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1","volume":"66","author":"Hartz","year":"2004","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0630","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1124\/mol.105.017954","article-title":"Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide","volume":"69","author":"Hartz","year":"2006","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0635","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/mol.109.061754","article-title":"Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-\u03b2 in a mouse model of Alzheimer's disease","volume":"77","author":"Hartz","year":"2010","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0640","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1021\/acs.molpharmaceut.6b00770","article-title":"P-gp protein expression and transport activity in rodent seizure models and human epilepsy","volume":"14","author":"Hartz","year":"2017","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0645","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.tips.2008.03.007","article-title":"Parkinson's disease and pesticides: A toxicological perspective","volume":"29","author":"Hatcher","year":"2008","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0650","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1523\/JNEUROSCI.5103-09.2010","article-title":"Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor","volume":"30","author":"Hawkins","year":"2010","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0655","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/sj.jcbfm.9600254","article-title":"HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier","volume":"26","author":"Hayashi","year":"2006","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0660","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1471-4159.2005.03114.x","article-title":"HIV-tat protein induces P-glycoprotein expression in brain microvascular endothelial cells","volume":"93","author":"Hayashi","year":"2005","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2006.10.007","article-title":"A primer on the mechanics of P-glycoprotein the multidrug transporter","volume":"55","author":"Hennessy","year":"2007","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0670","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00170943","article-title":"P-glycoprotein expression in brain tumors","volume":"14","author":"Henson","year":"1992","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0675","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/156800906777441753","article-title":"Regulation of multidrug resistance by pro-inflammatory cytokines","volume":"6","author":"Ho","year":"2006","journal-title":"Current Cancer Drug Targets"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0680","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrneurol.2016.111","article-title":"Supportive and symptomatic management of amyotrophic lateral sclerosis","volume":"12","author":"Hobson","year":"2016","journal-title":"Nature Reviews. Neurology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0685","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2174\/15672050113106660171","article-title":"Reduced Alzheimer's disease pathology by St. John's Wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice","volume":"10","author":"Hofrichter","year":"2013","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0690","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1471-4159.2006.03993.x","article-title":"Up-regulation of P-glycoprotein expression by glutathione depletion-induced oxidative stress in rat brain microvessel endothelial cells","volume":"98","author":"Hong","year":"2006","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0695","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/0271678X18822801","article-title":"Oxidative stress-induced activation of Abl and Src kinases rapidly induces P-glycoprotein internalization via phosphorylation of caveolin-1 on tyrosine-14, decreasing cortisol efflux at the blood-brain barrier","volume":"40","author":"Hoshi","year":"2019","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0700","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/jnc.13960","article-title":"Actin filament-associated protein 1 (AFAP-1) is a key mediator in inflammatory signaling-induced rapid attenuation of intrinsic P-gp function in human brain capillary endothelial cells","volume":"141","author":"Hoshi","year":"2017","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0705","doi-asserted-by":"crossref","first-page":"850493","DOI":"10.1155\/2014\/850493","article-title":"An in vivo microdialysis study of FLZ penetration through the blood-brain barrier in normal and 6-hydroxydopamine induced Parkinson's disease model rats","volume":"2014","author":"Hou","year":"2014","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0710","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpba.2012.03.001","article-title":"Quantitative determination and pharmacokinetic study of the novel anti-Parkinson's disease candidate drug FLZ in rat brain by high performance liquid chromatography-tandem mass spectrometry","volume":"66","author":"Hou","year":"2012","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0715","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/346362a0","article-title":"Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport","volume":"346","author":"Hyde","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0720","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.clinpsy.3.022806.091532","article-title":"The diagnosis of mental disorders: The problem of reification","volume":"6","author":"Hyman","year":"2010","journal-title":"Annual Review of Clinical Psychology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0725","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0730","article-title":"Pro-inflammatory cytokine regulation of P-glycoprotein in the developing blood-brain barrier","volume":"7","author":"Iqbal","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0735","series-title":"Handbook of Clinical Neurology","first-page":"393","article-title":"Prion diseases","volume":"Vol. 145","author":"Ironside","year":"2017"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0740","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1021\/acschemneuro.7b00517","article-title":"Acute neurotoxicity models of Prion disease","volume":"9","author":"Islam","year":"2018","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0745","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nbd.2012.03.040","article-title":"Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS","volume":"47","author":"Jablonski","year":"2012","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0750","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/acn3.141","article-title":"Inhibiting drug efflux transporters improves efficacy of ALS therapeutics","volume":"1","author":"Jablonski","year":"2014","journal-title":"Annals of Clinical and Translational Neurology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0755","doi-asserted-by":"crossref","DOI":"10.1038\/srep26801","article-title":"Plasma \u03b2-amyloid in Alzheimer's disease and vascular disease","volume":"6","author":"Janelidze","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0765","series-title":"Antidepressants: Clinical psychopharmacology for neurologists","author":"Jennings","year":"2018"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0770","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1568026619666190412121811","article-title":"ABC transporters in neurological disorders: An important gateway for botanical compounds mediated Neuro-therapeutics","volume":"19","author":"Jha","year":"2019","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0775","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0780","doi-asserted-by":"crossref","first-page":"15067","DOI":"10.1038\/nrdp.2015.67","article-title":"Schizophrenia","volume":"1","author":"Kahn","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0785","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease. Parkinson's disease","author":"Kalia","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0790","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrneurol.2015.249","article-title":"Parkinson disease in 2015: Evolving basic, pathological and clinical concepts in PD","volume":"12","author":"Kalia","year":"2016","journal-title":"Nat Rev Nature reviews Neurology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0795","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2011.08.044","article-title":"Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells","volume":"1418","author":"Kania","year":"2011","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0800","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1016\/j.ejca.2006.07.013","article-title":"Development of luciferase tagged brain tumour models in mice for chemotherapy intervention studies","volume":"42","author":"Kemper","year":"2006","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0805","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ejca.2004.01.024","article-title":"Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein","volume":"40","author":"Kemper","year":"2004","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0810","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0815","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/brain\/awn222","article-title":"ABCC1: A gateway for pharmacological compounds to the ischaemic brain","volume":"131","author":"Kilic","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0820","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.seizure.2006.02.015","article-title":"Lack of association between C3435T nucleotide MDR1 genetic polymorphism and multidrug-resistant epilepsy","volume":"15","author":"Kim","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0825","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.eplepsyres.2008.12.001","article-title":"Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy","volume":"84","author":"Kim","year":"2009","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0835","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1471-4159.2003.02181.x","article-title":"An ALS mouse model with a permeable blood-brain barrier benefits from systemic cyclosporine a treatment","volume":"88","author":"Kirkinezos","year":"2004","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0840","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2009.10.001","article-title":"The complexities of antiretroviral drug-drug interactions: Role of ABC and SLC transporters","volume":"31","author":"Kis","year":"2010","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0845","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/187152411798047744","article-title":"The role of p-glycoprotein in psychiatric disorders: A reliable guard of the brain?","volume":"11","author":"de Klerk","year":"2011","journal-title":"Central Nervous System Agents in Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0850","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/tpj.2012.16","article-title":"ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder","volume":"13","author":"de Klerk","year":"2013","journal-title":"The Pharmacogenomics Journal"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0855","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pscychresns.2010.05.002","article-title":"Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia: A PET study with [(11)C]verapamil as a probe for P-glycoprotein function","volume":"183","author":"de Klerk","year":"2010","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0860","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1017\/S1461145709009894","article-title":"Locally increased P-glycoprotein function in major depression: A PET study with [11C]verapamil as a probe for P-glycoprotein function in the blood-brain barrier","volume":"12","author":"de Klerk","year":"2009","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0865","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00401-014-1244-8","article-title":"P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma","volume":"127","author":"Kooij","year":"2014","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0870","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/brain\/awq330","article-title":"Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: Relevance to multiple sclerosis pathogenesis","volume":"134","author":"Kooij","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0875","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2012.00074","article-title":"The role of ATP-binding cassette transporters in neuro-inflammation: Relevance for bioactive lipids","volume":"3","author":"Kooij","year":"2012","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0880","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jaut.2009.10.006","article-title":"T lymphocytes impair P-glycoprotein function during neuroinflammation","volume":"34","author":"Kooij","year":"2010","journal-title":"Journal of Autoimmunity"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0885","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.phrs.2015.09.003","article-title":"Brain accumulation of the EML4-ALK inhibitor ceritinib is restricted by P-glycoprotein (P-GP\/ABCB1) and breast cancer resistance protein (BCRP\/ABCG2)","volume":"102","author":"Kort","year":"2015","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0890","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.20369","article-title":"Blood-brain barrier dysfunction in parkinsonian midbrain in vivo","volume":"57","author":"Kortekaas","year":"2005","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0900","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1172\/JCI57867","article-title":"Cerebral amyloid-\u03b2 proteostasis is regulated by the membrane transport protein ABCC1 in mice","volume":"121","author":"Krohn","year":"2011","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0905","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1038\/sj.onc.1206953","article-title":"The MRP family of drug efflux pumps","volume":"22","author":"Kruh","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0910","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/1471-2407-10-468","article-title":"MRP3: A molecular target for human glioblastoma multiforme immunotherapy","volume":"10","author":"Kuan","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0915","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1750-3639.2007.00075.x","article-title":"MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer's Amyloid-\u03b2 peptides-implications for the mechanisms of A\u03b2 clearance at the blood\u2013brain barrier","volume":"17","author":"Kuhnke","year":"2007","journal-title":"Brain Pathology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0920","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: Consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0925","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yebeh.2007.04.013","article-title":"Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese","volume":"11","author":"Kwan","year":"2007","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0930","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1046\/j.1471-4159.2001.00113.x","article-title":"\u03b2-Amyloid efflux mediated by p-glycoprotein","volume":"76","author":"Lam","year":"2001","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0935","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2174\/138945008785132349","article-title":"Ceramide kinase and the ceramide-1-phosphate\/cPLA2alpha interaction as a therapeutic target","volume":"9","author":"Lamour","year":"2008","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0940","doi-asserted-by":"crossref","first-page":"42808","DOI":"10.1074\/jbc.M111.310169","article-title":"Ceramide kinase regulates the production of tumor necrosis factor alpha (TNFalpha) via inhibition of TNFalpha-converting enzyme","volume":"286","author":"Lamour","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0945","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0950","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.addr.2004.07.009","article-title":"Potential role of ABC transporters as a detoxification system at the blood-CSF barrier","volume":"56","author":"de Lange","year":"2004","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0955","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jns.2007.03.004","article-title":"Neuronal mdr-1 gene expression after experimental focal hypoxia: A new obstacle for neuroprotection?","volume":"258","author":"Lazarowski","year":"2007","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0960","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.phrs.2019.04.031","article-title":"ABC transporters in drug-resistant epilepsy: Mechanisms of upregulation and therapeutic approaches","volume":"144","author":"Leandro","year":"2019","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0965","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.cell.2017.02.033","article-title":"Transporters revealed","volume":"168","author":"Lee","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0975","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1021\/jm00180a022","article-title":"Relationship of octanol\/water partition coefficient and molecular weight to rat brain capillary permeability","volume":"23","author":"Levin","year":"1980","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0980","article-title":"P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0985","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/ahg.12258","article-title":"Association of ABCG2 polymorphisms with ischemic stroke in a Chinese population","volume":"82","author":"Liu","year":"2018","journal-title":"Annals of Human Genetics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0990","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1089\/gtmb.2013.0313","article-title":"Pesticide-induced gene mutations and Parkinson disease risk: A meta-analysis","volume":"17","author":"Liu","year":"2013","journal-title":"Genetic Testing and Molecular Biomarkers"},{"key":"10.1016\/j.pharmthera.2020.107554_bb0995","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejps.2017.05.009","article-title":"Intestinal absorption mechanisms of 2\u2032-deoxy-2\u2032-beta-fluoro-4\u2032-azidocytidine, a cytidine analog for AIDS treatment, and its interaction with P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein","volume":"105","author":"Liu","year":"2017","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1000","first-page":"503","article-title":"Effects of the antiretroviral drug 2\u2032-deoxy-2\u2032-beta-fluoro-4\u2032-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions","volume":"73","author":"Liu","year":"2018","journal-title":"Pharmazie"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1124\/jpet.301.1.7","article-title":"Role of multidrug transporters in pharmacoresistance to antiepileptic drugs","volume":"301","author":"Loscher","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","article-title":"Blood-brain barrier active efflux transporters: ATP-binding cassette gene family","volume":"2","author":"Loscher","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"Loscher","year":"2005","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pneurobio.2005.04.006","article-title":"Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases","volume":"76","author":"Loscher","year":"2005","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1030","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: The 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/STROKEAHA.108.521328","article-title":"Gene variants associated with ischemic stroke: The cardiovascular health study","volume":"40","author":"Luke","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1040","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1124\/jpet.114.218180","article-title":"Glutamate-mediated upregulation of the multidrug resistance protein 2 in porcine and human brain capillaries","volume":"352","author":"Luna-Munguia","year":"2015","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1045","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.12688\/f1000research.12681.1","article-title":"Creutzfeldt-Jakob disease: Recent developments","volume":"6","author":"Mackenzie","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1050","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuron.2015.03.035","article-title":"A cellular perspective on brain energy metabolism and functional imaging","volume":"86","author":"Magistretti","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1517\/17425255.2016.1168804","article-title":"ABC transporters at the blood-brain barrier","volume":"12","author":"Mahringer","year":"2016","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12248-014-9668-6","article-title":"Role of the breast cancer resistance protein (BCRP\/ABCG2) in drug transport-an update","volume":"17","author":"Mao","year":"2015","journal-title":"The AAPS Journal"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1070","doi-asserted-by":"crossref","first-page":"a008870","DOI":"10.1101\/cshperspect.a008870","article-title":"Clinical approach to Parkinson's disease: Features, diagnosis, and principles of management","volume":"2","author":"Massano","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1075","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer's disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nature Reviews. Disease Primers"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1080","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41582-019-0240-y","article-title":"Chronic inflammation in multiple sclerosis - seeing what was always there","volume":"15","author":"Matthews","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1085","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS \u03b2-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1090","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.amjmed.2017.12.039","article-title":"Brain tumors","volume":"131","author":"McFaline-Figueroa","year":"2018","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1095","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1208\/s12248-017-0077-5","article-title":"Neurovascular alterations in Alzheimer's disease: Transporter expression profiles and CNS drug access","volume":"19","author":"McInerney","year":"2017","journal-title":"The AAPS Journal"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1100","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jac\/dkf161","article-title":"P-glycoprotein and MRP1 expression and reduced ritonavir and saquinavir accumulation in HIV-infected individuals","volume":"50","author":"Meaden","year":"2002","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1105","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.physiol.64.082201.100300","article-title":"Bile salt transporters","volume":"64","author":"Meier","year":"2002","journal-title":"Annual Review of Physiology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1115","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3389\/fnins.2019.00750","article-title":"Convulsive stress mimics brain hypoxia and promotes the P-Glycoprotein (P-gp) and erythropoietin receptor overexpression. Recombinant human erythropoietin effect on P-gp activity","volume":"13","author":"Merelli","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1120","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3171\/jns.2005.103.5.0853","article-title":"A reassessment of vascular endothelial growth factor in central nervous system pathology","volume":"103","author":"Merrill","year":"2005","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1124\/mol.116.107169","article-title":"Ceramide 1-phosphate increases P-glycoprotein transport activity at the blood-brain barrier via prostaglandin E2 signaling","volume":"91","author":"Mesev","year":"2017","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4137\/PMC.S13384","article-title":"Pathways for small molecule delivery to the central nervous system across the blood-brain barrier","volume":"6","author":"Mikitsh","year":"2014","journal-title":"Perspect Medicin Chem"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1140","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neulet.2010.01.078","article-title":"P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis","volume":"472","author":"Milane","year":"2010","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1471-4159.2007.04772.x","article-title":"Minocycline and riluzole brain disposition: Interactions with p-glycoprotein at the blood-brain barrier","volume":"103","author":"Milane","year":"2007","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.18433\/J36C78","article-title":"Brain and plasma riluzole pharmacokinetics: Effect of minocycline combination","volume":"12","author":"Milane","year":"2009","journal-title":"Journal of Pharmacy & Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2008.12.061","article-title":"Interactions between riluzole and ABCG2\/BCRP transporter","volume":"452","author":"Milane","year":"2009","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1160","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.tips.2010.03.003","article-title":"Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier","volume":"31","author":"Miller","year":"2010","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apha.2014.06.008","article-title":"ABC transporter regulation by signaling at the blood-brain barrier: Relevance to pharmacology","volume":"71","author":"Miller","year":"2014","journal-title":"Advances in Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.acr.2014.10.002","article-title":"Chapter two-regulation of ABC transporters blood\u2013brain barrier: The good, the bad, and the ugly","volume":"125","author":"Miller","year":"2015","journal-title":"Advances in Cancer Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1175","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/cpt.64","article-title":"Regulation of ABC transporters at the blood-brain barrier","volume":"97","author":"Miller","year":"2015","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1180","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/pr.107.07109","article-title":"Modulation of P-glycoprotein at the blood-brain barrier: Opportunities to improve central nervous system pharmacotherapy","volume":"60","author":"Miller","year":"2008","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1185","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1093\/jac\/dkw215","article-title":"P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load","volume":"71","author":"Minuesa","year":"2016","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12883-018-1055-y","article-title":"Creutzfeldt-Jakob disease with Alzheimer pathology, presenting with status epilepticus following repeated partial seizures: A case report and literature review","volume":"18","author":"Miyake","year":"2018","journal-title":"BMC Neurology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eplepsyres.2010.12.013","article-title":"Antiepileptic drugs modulate P-glycoproteins in the brain: A mice study with [11C]-desmethylloperamide","volume":"94","author":"Moerman","year":"2011","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1200","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1208\/s12248-017-0120-6","article-title":"Blood-brain barrier driven pharmacoresistance in amyotrophic lateral sclerosis and challenges for effective drug therapies","volume":"19","author":"Mohamed","year":"2017","journal-title":"The AAPS Journal"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1205","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.expneurol.2019.04.002","article-title":"Excess glutamate secreted from astrocytes drives upregulation of P-glycoprotein in endothelial cells in amyotrophic lateral sclerosis","volume":"316","author":"Mohamed","year":"2019","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2015.03.001","article-title":"Prediction of drug-ABC-transporter interaction--recent advances and future challenges","volume":"86","author":"Montanari","year":"2015","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2015.07.013","article-title":"Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells","volume":"367","author":"Munoz","year":"2015","journal-title":"Cancer Letters"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1220","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/BF00227747","article-title":"The coexistence of Alzheimer's disease and Creutzfeldt-Jakob disease in a patient with dementia of long duration","volume":"84","author":"Muramoto","year":"1992","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1225","doi-asserted-by":"crossref","first-page":"C440","DOI":"10.1152\/ajpcell.00491.2007","article-title":"Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier","volume":"295","author":"Narang","year":"2008","journal-title":"American Journal of Physiology-Cell Physiology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1230","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.envres.2015.08.022","article-title":"Genetic variability in ABCB1, occupational pesticide exposure, and Parkinson's disease","volume":"143","author":"Narayan","year":"2015","journal-title":"Environmental Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1235","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuroscience.2004.07.051","article-title":"Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain","volume":"129","author":"Nies","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1240","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/1568010042634541","article-title":"Nuclear receptors: Overview and classification","volume":"3","author":"Novac","year":"2004","journal-title":"Current Drug Targets-Inflammation & Allergy"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1245","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1046\/j.1471-4159.2003.02061.x","article-title":"Signalling pathways influencing basal and H(2)O(2)-induced P-glycoprotein expression in endothelial cells derived from the blood-brain barrier","volume":"87","author":"Nwaozuzu","year":"2003","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ctrv.2008.09.004","article-title":"The biological and clinical role of drug transporters at the intestinal barrier","volume":"35","author":"Oostendorp","year":"2009","journal-title":"Cancer Treatment Reviews"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1255","first-page":"G1493","article-title":"MRP3, a new ATP-binding cassette protein localized to the canalicular domain of the hepatocyte","volume":"276","author":"Ortiz","year":"1999","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1260","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.arcmed.2014.11.013","article-title":"Role of the blood-brain barrier in multiple sclerosis","volume":"45","author":"Ortiz","year":"2014","journal-title":"Archives of Medical Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1265","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia","volume":"388","author":"Owen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1270","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.nbd.2014.04.001","article-title":"Alzheimer's and ABC transporters--new opportunities for diagnostics and treatment","volume":"72","author":"Pahnke","year":"2014","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: Bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1280","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.258","article-title":"A\u03b21\u201342 reduces P-glycoprotein in the blood-brain barrier through RAGE\u2013NF-\u03baB signaling","volume":"5","author":"Park","year":"2014","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1285","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.2174\/138161211797440195","article-title":"ATP-binding cassette transporters at the blood-brain barrier in ischaemic stroke","volume":"17","author":"Patak","year":"2011","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1290","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2040-7378-3-12","article-title":"The ATP-binding cassette transporters ABCB1 and ABCC1 are not regulated by hypoxia in immortalised human brain microvascular endothelial cells","volume":"3","author":"Patak","year":"2011","journal-title":"Experimental & Translational Stroke Medicine"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1295","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1124\/jpet.109.152520","article-title":"Targeting prostaglandin E2 EP1 receptors prevents seizure-associated P-glycoprotein up-regulation","volume":"330","author":"Pekcec","year":"2009","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1300","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrc2789-c1","article-title":"The ABC of glycosylation","volume":"10","author":"Perego","year":"2010","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1305","article-title":"Drug-resistant epilepsy: From multiple hypotheses to an integral explanation using preclinical resources","volume":"106430","author":"Perez-Perez","year":"2019","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1310","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1743-8977-3-13","article-title":"Translocation and potential neurological effects of fine and ultrafine particles a critical update","volume":"3","author":"Peters","year":"2006","journal-title":"Particle and Fibre Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1315","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1471-4159.2006.04295.x","article-title":"Modulation of P-glycoprotein function by sphingosine kinase-1 in brain endothelial cells","volume":"100","author":"Pilorget","year":"2007","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1320","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S2215-0366(17)30293-6","article-title":"The blood-brain barrier in psychosis","volume":"5","author":"Pollak","year":"2017","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1325","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1124\/jpet.103.049858","article-title":"Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity","volume":"306","author":"Potschka","year":"2003","journal-title":"Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1330","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.neuropharm.2014.01.023","article-title":"Differences in amyloid-\u03b2 clearance across mouse and human blood\u2013brain barrier models: Kinetic analysis and mechanistic modeling","volume":"79","author":"Qosa","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1335","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2012-120319","article-title":"Enhanced brain amyloid-\u03b2 clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer's disease","volume":"31","author":"Qosa","year":"2012","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1340","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/glia.23003","article-title":"Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-glycoprotein) in endothelial cells of the blood-brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis","volume":"64","author":"Qosa","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1345","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.brainres.2015.07.005","article-title":"Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders","volume":"1628","author":"Qosa","year":"2015","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1350","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/2165079916665400","article-title":"Ischemic Stroke","volume":"64","author":"Randolph","year":"2016","journal-title":"Workplace Health Saf"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1355","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1013104423154","article-title":"Multidrug resistance in brain tumors: Roles of the blood-brain barrier","volume":"20","author":"R\u00e9gina","year":"2001","journal-title":"Metastasis Reviews"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1360","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1124\/mol.63.5.1094","article-title":"Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5","volume":"63","author":"Reid","year":"2003","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1370","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0889-1591(02)00055-7","article-title":"Molecular insights on the cerebral innate immune system","volume":"17","author":"Rivest","year":"2003","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1375","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1471-4159.2009.06306.x","article-title":"P-glycoprotein expression in immortalised rat brain endothelial cells: Comparisons following exogenously applied hydrogen peroxide and after hypoxia-reoxygenation","volume":"111","author":"Robertson","year":"2009","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1380","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbrc.2014.01.092","article-title":"Expression of ATP-binding cassette membrane transporters in a HIV-1 transgenic rat model","volume":"444","author":"Robillard","year":"2014","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2020.107554_bb1385","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/epi.12182","article-title":"The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs","volume":"54","author":"Rogawski","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1390","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1124\/mol.106.025973","article-title":"HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein","volume":"70","author":"Ronaldson","year":"2006","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1395","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/j.1471-4159.2008.05479.x","article-title":"HIV-1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein-1 (Mrp1) in glial cells","volume":"106","author":"Ronaldson","year":"2008","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1400","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tips.2008.01.006","article-title":"Multidrug resistance protein 4 (MRP4\/ABCC4): A versatile efflux transporter for drugs and signalling molecules","volume":"29","author":"Russel","year":"2008","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1405","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/0269881119827959","article-title":"Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics","volume":"33","author":"Saiz-Rodriguez","year":"2019","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1410","first-page":"333","article-title":"ATP-binding cassette transporters in primary central nervous system lymphoma: Decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells","volume":"25","author":"Sakata","year":"2011","journal-title":"Oncology Reports"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1415","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1021\/acs.molpharmaceut.9b00018","article-title":"Validation of thiosemicarbazone compounds as P-glycoprotein inhibitors in human primary brain-blood barrier and glioblastoma stem cells","volume":"16","author":"Salaroglio","year":"2019","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1420","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1021\/mp500841w","article-title":"Glutamate-mediated down-regulation of the multidrug-resistance protein BCRP\/ABCG2 in porcine and human brain capillaries","volume":"12","author":"Salvamoser","year":"2015","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1425","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson's disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1430","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/01616412.1994.11740231","article-title":"P-glycoprotein expression in brain capillary endothelial cells after focal ischaemia in the rat","volume":"16","author":"Samoto","year":"1994","journal-title":"Neurological Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1435","first-page":"257","article-title":"P-glycoprotein expression in brain capillary endothelial cells after focal ischemia in rat","volume":"60","author":"Samoto","year":"1994","journal-title":"Acta Neurochirurgica. Supplementum (Wien)"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1440","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.nbd.2008.08.005","article-title":"Blood-brain barrier tight junction permeability and ischemic stroke","volume":"32","author":"Sandoval","year":"2008","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1445","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.febslet.2004.03.123","article-title":"ABCG2 \u2013 A transporter for all seasons","volume":"567","author":"Sarkadi","year":"2004","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1450","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/labinvest.3780411","article-title":"Tissue distribution and induction of human multidrug resistant protein 3","volume":"82","author":"Scheffer","year":"2002","journal-title":"Laboratory Investigation"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1455","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0169-409X(98)00085-4","article-title":"P-glycoprotein, a gatekeeper in the blood-brain barrier","volume":"36","author":"Schinkel","year":"1999","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1460","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1465","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/med.20064","article-title":"Neutrophils and the blood-brain barrier dysfunction after trauma","volume":"27","author":"Scholz","year":"2007","journal-title":"Medicinal Research Reviews"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1470","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1212\/01.CON.0000466664.35650.b4","article-title":"Depression","volume":"21","author":"Schulz","year":"2015","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1475","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-2001-3111","article-title":"Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein","volume":"3","author":"Selkoe","year":"2001","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1480","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1485","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2217\/14622416.9.1.105","article-title":"ABC multidrug transporters: Structure, function and role in chemoresistance","volume":"9","author":"Sharom","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1490","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/bse0500161","article-title":"The P-glycoprotein multidrug transporter","volume":"50","author":"Sharom","year":"2011","journal-title":"Essays in Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1495","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1471-4159.2010.06887.x","article-title":"ABCG2 reduces ROS-mediated toxicity and inflammation: A potential role in Alzheimer's disease","volume":"114","author":"Shen","year":"2010","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1500","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer's amyloid-\u03b21-40 peptide from brain by LDL receptor\u2013related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1510","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMoa021986","article-title":"Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1","volume":"348","author":"Siddiqui","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1515","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1525-5050(02)00511-5","article-title":"P-glycoprotein-mediated efflux of antiepileptic drugs: Preliminary studies in mdr1a knockout mice","volume":"3","author":"Sills","year":"2002","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1520","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s00204-014-1333-4","article-title":"P-glycoprotein induction in Caco-2 cells by newly synthetized thioxanthones prevents paraquat cytotoxicity","volume":"89","author":"Silva","year":"2015","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.11.013","article-title":"Modulation of P-glycoprotein efflux pump: Induction and activation as a therapeutic strategy","volume":"149","author":"Silva","year":"2015","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1535","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/anie.201204964","article-title":"Alzheimer's disease, cholesterol, and statins: The junctions of important metabolic pathways","volume":"52","author":"Silva","year":"2013","journal-title":"Angewandte Chemie (International Ed. in English)"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1540","article-title":"Tumors: Benign and malignant","volume":"10","author":"Sinha","year":"2018","journal-title":"Canc Therapy & Oncol Int J"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1545","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00019052-200304000-00013","article-title":"Mechanisms of antiepileptic drug resistance","volume":"16","author":"Sisodiya","year":"2003","journal-title":"Current Opinion in Neurology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1550","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1097\/00001756-199911080-00032","article-title":"Over-expression of P-glycoprotein in malformations of cortical development","volume":"10","author":"Sisodiya","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1555","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/brain\/awf002","article-title":"Drug resistance in epilepsy: Expression of drug resistance proteins in common causes of refractory epilepsy","volume":"125","author":"Sisodiya","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1560","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13760-016-0690-6","article-title":"Associations between MDR1 C3435T polymorphism and drug-resistant epilepsy in the polish population","volume":"117","author":"Skalski","year":"2017","journal-title":"Acta Neurologica Belgica"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1570","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1517\/14656566.6.8.1305","article-title":"The role of common variation in drug transporter genes in refractory epilepsy","volume":"6","author":"Soranzo","year":"2005","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009505","article-title":"The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide","volume":"5","author":"Soscia","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1580","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nn1676","article-title":"Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia","volume":"9","author":"Spudich","year":"2006","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1585","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/cmdc.200900283","article-title":"Activators of P-glycoprotein: Structure-activity relationships and investigation of their mode of action","volume":"4","author":"Sterz","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1590","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnins.2015.00021","article-title":"Efflux transporters in blood-brain interfaces of the developing brain","volume":"9","author":"Strazielle","year":"2015","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1595","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0169-409X(02)00172-2","article-title":"Drug efflux transporters in the CNS","volume":"55","author":"Sun","year":"2003","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1600","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1212\/01.WNL.0000137051.33486.C7","article-title":"Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy","volume":"63","author":"Tan","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1605","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fneur.2017.00301","article-title":"Drug-resistant epilepsy: Multiple hypotheses, few answers","volume":"8","author":"Tang","year":"2017","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2012.04.021","article-title":"The role of astrocytes in amyloid \u03b2-protein toxicity and clearance","volume":"236","author":"Thal","year":"2012","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1615","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1042\/BST20150139","article-title":"ABC transporter research: Going strong 40 years on","volume":"43","author":"Theodoulou","year":"2015","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1620","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues","volume":"84","author":"Thiebaut","year":"1987","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1157.1995.tb01657.x","article-title":"MDR1 gene expression in brain of patients with medically intractable epilepsy","volume":"36","author":"Tishler","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1630","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer's disease: Pathogenesis, diagnostics, and therapeutics","volume":"14","author":"Tiwari","year":"2019","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1635","first-page":"853","article-title":"MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors","volume":"149","author":"T\u00f3th","year":"1996","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1640","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1440-1789.2003.00513.x","article-title":"Coexistence of CJD and Alzheimer's disease: An autopsy case showing typical clinical features of CJD","volume":"24","author":"Tsuchiya","year":"2004","journal-title":"Neuropathology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1645","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1007\/s12035-018-1237-z","article-title":"APOE and Alzheimer's disease: Evidence mounts that targeting APOE4 may combat Alzheimer's pathogenesis","volume":"56","author":"Uddin","year":"2019","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1655","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2990.2008.00966.x","article-title":"The expression of P-glycoprotein is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model","volume":"35","author":"Ueno","year":"2009","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1660","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s00401-004-0845-z","article-title":"Blood-brain barrier is impaired in the hippocampus of young adult spontaneously hypertensive rats","volume":"107","author":"Ueno","year":"2004","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1665","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1479-7364-3-3-281","article-title":"Human ATP-binding cassette (ABC) transporter family","volume":"3","author":"Vasiliou","year":"2009","journal-title":"Human Genomics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1670","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5698\/1535-7511-14.s2.3","article-title":"Epilepsy and inflammation in the brain: Overview and pathophysiology","volume":"14","author":"Vezzani","year":"2014","journal-title":"Epilepsy currents"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1675","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nature Reviews Neurology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1685","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1528-1167.2005.00250.x","article-title":"Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats","volume":"46","author":"van Vliet","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1690","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00008571-200210000-00005","article-title":"Deposition of Alzheimer's \u03b2-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans","volume":"12","author":"Vogelgesang","year":"2002","journal-title":"Pharmacogenetics and Genomics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1695","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00401-006-0042-3","article-title":"Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease","volume":"111","author":"Vogelgesang","year":"2006","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1700","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/dna.2017.4096","article-title":"ABCB1 1199G > a polymorphism impacts transport ability of P-gp-mediated antipsychotics","volume":"37","author":"Wang","year":"2018","journal-title":"DNA and Cell Biology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1705","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2174\/1567205013666160314151012","article-title":"A role for P-glycoprotein in clearance of Alzheimer amyloid \u03b2-peptide from the brain","volume":"13","author":"Wang","year":"2016","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1710","doi-asserted-by":"crossref","first-page":"8585","DOI":"10.1523\/JNEUROSCI.2935-13.2014","article-title":"Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers","volume":"34","author":"Wang","year":"2014","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1715","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1096\/fj.10-169227","article-title":"Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier","volume":"25","author":"Wang","year":"2011","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1720","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1124\/mol.110.063685","article-title":"Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier","volume":"78","author":"Wang","year":"2010","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1725","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1471-4159.2009.06305.x","article-title":"Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro","volume":"111","author":"von Wedel-Parlow","year":"2009","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1730","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jac\/dkl474","article-title":"Modulation of human BCRP (ABCG2) activity by anti-HIV drugs","volume":"59","author":"Weiss","year":"2007","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1735","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2008.02.016","article-title":"Effect of 21-day exposure of phenobarbital, carbamazepine and phenytoin on P-glycoprotein expression and activity in the rat brain","volume":"270","author":"Wen","year":"2008","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1740","first-page":"7","article-title":"Neuropathologic changes in Alzheimer's disease","volume":"64","author":"Wenk","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1745","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00441-008-0686-5","article-title":"Expression of multi-drug resistance 1 mRNA in human and rodent tissues: Reduced levels in Parkinson patients","volume":"334","author":"Westerlund","year":"2008","journal-title":"Cell and Tissue Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1755","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122544","article-title":"Obstacles to brain tumor therapy: Key ABC transporters","volume":"18","author":"Wijaya","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1760","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.brainres.2010.08.034","article-title":"ABC efflux transporters in brain vasculature of Alzheimer's subjects","volume":"1358","author":"Wijesuriya","year":"2010","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1765","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1537-1891(02)00200-8","article-title":"Tight junctions of the blood-brain barrier: Development, composition and regulation","volume":"38","author":"Wolburg","year":"2002","journal-title":"Vascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1775","series-title":"Epilepsy","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1780","series-title":"Depression","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1785","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1211\/jpp.61.06.0016","article-title":"Glutathione depletion upregulates P-glycoprotein expression at the blood-brain barrier in rats","volume":"61","author":"Wu","year":"2009","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1790","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neulet.2007.12.017","article-title":"Repetitive\/temporal hypoxia increased P-glycoprotein expression in cultured rat brain microvascular endothelial cells in vitro","volume":"432","author":"Xiao-Dong","year":"2008","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1795","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1523\/JNEUROSCI.5103-08.2009","article-title":"ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood\u2013brain barrier for A\u03b21\u201340 peptides","volume":"29","author":"Xiong","year":"2009","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1800","doi-asserted-by":"crossref","first-page":"19781","DOI":"10.1074\/jbc.M310785200","article-title":"Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2","volume":"279","author":"Xu","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1805","article-title":"Sporadic Creutzfeldt-Jakob disease presenting as dizziness and cognitive decline: A case report","volume":"98","author":"Xu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1810","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejps.2018.04.026","article-title":"Verapamil and riluzole cocktail liposomes overcome pharmacoresistance by inhibiting P-glycoprotein in brain endothelial and astrocyte cells: A potent approach to treat amyotrophic lateral sclerosis","volume":"120","author":"Yang","year":"2018","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1815","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/13880209.2019.1582679","article-title":"Regulation of P-glycoprotein by Bajijiasu in vitro and in vivo by activating the Nrf2-mediated signalling pathway","volume":"57","author":"Yang","year":"2019","journal-title":"Pharmaceutical Biology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1820","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2133\/dmpk.DMPK-13-RG-072","article-title":"Role of P-glycoprotein in regulating cilnidipine distribution to intact and ischemic brain","volume":"29","author":"Yano","year":"2014","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1825","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1096\/fj.02-0285fje","article-title":"Function of beta-amyloid in cholesterol transport: A lead to neurotoxicity","volume":"16","author":"Yao","year":"2002","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1830","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1471-4159.2012.07890.x","article-title":"Induction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA\/COX-2 activation","volume":"123","author":"Yousif","year":"2012","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1835","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.preghy.2019.08.002","article-title":"The potentially protective role of ATP-binding cassette transporters in preeclampsia via Nrf2","volume":"18","author":"Yu","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1840","doi-asserted-by":"crossref","unstructured":"Zaman, G. J., Flens, M. J., van Leusden, M. R., de Haas, M., Mulder, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., Broxterman, H. J., & et al. (1994). The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proceedings of the National Academy of Sciences of the United States of America, 91, 8822-8826.","DOI":"10.1073\/pnas.91.19.8822"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1845","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/jnr.21898","article-title":"Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line","volume":"87","author":"Zastre","year":"2009","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1850","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.prp.2018.08.011","article-title":"A new approach for Alzheimer's disease treatment through P-gp regulation via ibuprofen","volume":"214","author":"Zhang","year":"2018","journal-title":"Pathology, Research and Practice"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1855","article-title":"P-glycoprotein inhibitor Tariquidar potentiates efficacy of Astragaloside IV in experimental autoimmune encephalomyelitis mice","volume":"24","author":"Zhang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1860","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00210-005-0028-z","article-title":"TAP and TAP-like--brothers in arms?","volume":"372","author":"Zhao","year":"2006","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1865","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1515\/revneuro-2016-0060","article-title":"Role of ABC transporters in the pathology of Alzheimer's disease","volume":"28","author":"Zhao","year":"2017","journal-title":"Reviews in the Neurosciences"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1875","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/aid.2015.0117","article-title":"HIV-1 tat protein enhances expression and function of breast cancer resistance protein","volume":"32","author":"Zhou","year":"2016","journal-title":"AIDS Research and Human Retroviruses"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1880","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","article-title":"Neurovascular mechanisms of Alzheimer's neurodegeneration","volume":"28","author":"Zlokovic","year":"2005","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1885","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1750-3639.2005.tb00103.x","article-title":"Neurovascular pathways and Alzheimer Amyloid \u03b2-peptide","volume":"15","author":"Zlokovic","year":"2005","journal-title":"Brain Pathology"},{"key":"10.1016\/j.pharmthera.2020.107554_bb1890","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1523\/JNEUROSCI.22-12-04833.2002","article-title":"A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage","volume":"22","author":"Zou","year":"2002","journal-title":"The Journal of Neuroscience"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820300826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820300826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:10:57Z","timestamp":1759011057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725820300826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":357,"alternative-id":["S0163725820300826"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107554","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107554","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107554"}}